DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo

Alnylam Pharmaceuticals (NASDAQ: ALNY)

59.55 2.59 (4.55%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ALNY $59.55 4.55%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $52.38
Previous Close $56.96
Daily Range $51.51 - $61.75
52-Week Range $51.51 - $140.00
Market Cap $5.0B
P/E Ratio -21.82
Dividend (Yield) $0.00 (0.0%)
Volume 1,920,760
Average Daily Volume 1,093,378
Current FY EPS -$3.38

Sector

Healthcare

Industry

Drug Makers

Alnylam Pharmaceuticals (ALNY) Description

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. Website: http://www.alnylam.com/

News & Commentary Rss Feed

Why Alnylam Pharmaceuticals Tanked in January

Alnylam's shares couldn't escape the biotech bloodbath last month.

Alnylam (ALNY) Reports Wider Q4 Loss; Revenues Miss

Alnylam Pharmaceuticals (ALNY) Earnings Report: Q4 2015 Conference Call Transcript

Alnylam Pharmaceuticals' (ALNY) CEO John Maraganore on Q4 2015 Results - Earnings Call Transcript

Alnylam Pharmaceuticals (ALNY) Q4 2015 Results - Earnings Call Webcast

Is a Surprise Coming for Alnylam Pharmaceuticals (ALNY) This Earnings Season?

InsiderInsights.com Daily Round Up 2/3/16: Phillips 66, Dolby Labs, Liberty Interactive, General Fin

InsiderInsights.com Daily Round Up 2/3/16: Phillips 66, Dolby Labs, Liberty Interactive, General Finance

Weak On High Volume: Alnylam Pharmaceuticals (ALNY)

Credit Suisse Bullish On Most Big Pharma Names

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netfl

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

See More ALNY News...

ALNY's Top Competitors

ALNY $59.55 (4.55%)
Current stock: ALNY
AMGN $144.72 (2.30%)
Current stock: AMGN
GILD $89.44 (2.38%)
Current stock: GILD
BIIB $247.22 (0.86%)
Current stock: BIIB